Poor Medication Management of Parkinson's Disease During Hospital Admissions: Patients and Families Can Improve Their Hospital-Based Management

You can find out more about NPF's National Medical Director, Dr. Michael S. Okun, by also visiting the NPF Center of Excellence, University of Florida Center for Movement Disorders & Neurorestoration.

Patients with Parkinson’s disease know the huge difference missed medication dosages can add up to. In some cases of Parkinson’s disease, missed medication dosages can lead to complications such as falling and severe mood swings. The results of a study from the United Kingdom conducted by Derry and colleagues should serve as a wake-up call to hospitals around the globe. The study’s authors carefully examined surgical admissions to the Aberdeen Royal Infirmary over an 18 month period. A shocking 71% of Parkinson’s disease patients missed medication dosages. Roughly a third of them missed over 10% of their prescribed dosages. The authors estimated that 0.7 missed dosages occurred per patient per hospital day. Interestingly, in approximately 2/3 of the cases, no reasons were reported for missing dosages. Drugs that acted against Parkinson’s disease symptoms (e.g. dopamine blockers) were “prescribed in 41%, and administered in 22% of cases.”

My suspicion is that as eye opening as this study’s results are, this likely represents “more of the norm” in hospitals around the world. This study should help us generate and launch educational programs and initiatives aimed at educating hospital staff, physicians, patients, and families about the care of the hospitalized Parkinson’s disease patient. The NPF 2007 Summer Parkinson Report tackled this issue with an article by Chou and colleagues addressing the most frequently asked questions about Parkinson’s disease hospitalization. The article had “tear out style” checklists for hospital staff, as well as for patients and families. These types of educational materials need to readily available, and we as a Parkinson’s disease community need to advocate for the implementation of programs at every hospital claiming to be in the business of taking care of Parkinson’s disease patients.

There are both simple and complex issues that need to be addressed in managing a hospitalized Parkinson’s disease patient. One simple fix is to have the physician write the medication orders with specific times for medication administration. He or she should stress to the staff and to the staff leadership, the importance of medication timing to successful Parkinson’s disease management. Physicians and staff should be aware that abrupt withdrawal of dopaminergic medications could lead to a potentially life-threatening syndrome called neuroleptic malignant syndrome. Teams should also be aware that many anti-nausea drugs, many sedatives, and many drugs used to improve gastric mobility (e.g. phenergan, haldol, and metoclopramide) block dopamine receptors in the brain, and should not be given to the hospitalized Parkinson’s disease patient. Medication regimens can be complex to manage within the hospital setting, and a neurologist can help to smooth the transition between inpatient and outpatient care. A neurologist can help to make alternative recommendations for drugs, especially when pills cannot be taken by mouth. Therefore, the threshold for neurological consultation should be low. Finally, vigilance in identifying and treating urinary and lung infections especially early in their course, can help to decrease hospital based “confusional” states.

It won’t be easy to change the behavior of hospital-based physicians and their staff, but is possible through carefully designed and focused educational programs it is possible. The good news is that there remains a lot of potential for improvement in the care of the hospitalized Parkinson’s disease patient. I recommend to all of my Parkinson’s disease patients, and to their family members, to go ahead and step up and play the “educator role” when in the hospital. In the current absence of standardized educational programs for the care of the hospitalized Parkinson’s disease patient, families and patients actually have the best chance to effect a positive change, and to improve their own hospital-based management.

For more information:

Print this Checklist: "Information for Your Nurse and Doctor for Hospitalization"

Watch this Video: "What do Caregivers Need to Know About Hospital Stays and Complex Medication Regimens"

Selected References:

Derry CP, Shah KJ, Caie L, Counsell CE. Medication management in people with
Parkinson's disease during surgical admissions. Postgrad Med J. 2010
Jun;86(1016):334-7.

Kelvin L. Chou, M.D., Michael S. Okun, M.D., Hubert H. Fernandez, M.D., Diane Breslow, MSW, LCSW, Joseph H. Friedman, M.D. Five frequently asked questions about hospitalization for patients with Parkinson disease. The Parkinson Report, Summer, 2007

 

Posted: 7/1/2010 6:14:18 AM by Leilani Pearl


Browse current and archived What's Hot in PD? articles, the National Parkinson Foundation's monthly blog for people with Parkinson's written by our National Medical Director, Dr. Michael S. Okun. 

March 2014
Could Northera (Droxidopa) Be an Alternative Treatment for Low Blood Pressure and Passing Out Symptoms?

February 2014
The Dream of a Pill Free Existence and the Continuous Dopaminergic Pump for the Treatment of Parkinson's Disease

January 2014
Should I take Inosine to Raise my Uric Acid Levels and Treat my Parkinson’s Disease?

December 2013
Could Fungus and Mold be an Important Contributor to Parkinson’s Disease?

November 2013
Pimavanserin and the Hope for a Better Drug for Hallucinations and Psychosis in Parkinson’s Disease

October 2013
Halting of the Creatine Study

September 2013
The Importance of Identifying and Treating Caregiver Strain

August 2013
Putting Parkinson’s Disease Information into the Palm of Your Hand: Parkinson’s Enters the Smartphon

July 2013
What Parkinson’s Disease Patients Need to Know about H. Pylori Gastrointestinal Infections

June 2013
A2A Receptor Antagonists and Parkinson’s Disease Treatment

May 2013
Another Setback for Trophic Factor Treatment in Parkinson's Disease

April 2013
IPX066 and What Patients Really Want in New Carbidopa/Levodopa (Sinemet) Formulations

March 2013
The Weather Forecast for Parkinson’s Disease Calls for Worldwide Economic Storm

February 2013
Defeating the Barriers to Implementing Exercise Regimens in Parkinson’s Disease Patients

January 2013
When should you start medication therapy for Parkinson’s disease?

December 2012
Neurologist Care Reduces Hospitalizations in Parkinson's Disease

November 2012
A Victory in Court for Parkinson's Disease Patients who Require Ongoing Rehabilitative Therapies

October 2012
Given the recent FDA announcement about Mirapex (pramipexole), should I be worried about dopamine agonists?

September 2012
What about the new Parkinson’s Disease Vaccine? What should I know?

August 2012
Caffeine as a Potential Treatment for Parkinson’s Disease

July 2012
Time to Consider GPi DBS for Parkinson’s Disease: A Shift in the Practice of Patient Selection for DBS

June 2012
A New Treatment for Parkinson’s Disease-Related Constipation

May 2012
Too Many Pills: Improving Delivery Systems for Parkinson’s Disease Drugs

April 2012
Measuring Quality and Assessing Depression in Parkinson's Disease

March 2012
Watch out for Unexpected Obstacles if You Use a Cueing Strategy to Break Freezing of Gait in Parkinson’s Disease

February 2012
Pill Color, Generic Medications and Insurance Issues: Important Medication-Related Tips for the Parkinson’s Disease Patient

January 2012
Are Blood Tests for Parkinson’s Disease on the Horizon?

December 2011
Placing Stem Cells in Animal Models of Parkinson’s Disease: Another Important Step

November 2011
Important News for the Parkinson’s Disease Community: More Evidence that Sinemet and Madopar are Not Toxic and do Not Accelerate Disease Progression

October 2011
The Case for All Parkinson’s Disease Patients to be Co-managed by a Primary Care-Neurologist Team

September 2011
Scientists say Research on Brain Proteins Involved in Parkinson’s Disease is “Shaping” Up

August 2011
Who Actually Takes Care of Most of the Parkinson’s Patients Worldwide: The Need for Education and the Parkinson’s Toolkit

July 2011
If you are Dizzy or Passing Out, it could be Your Parkinson’s Disease or Parkinson’s Disease Medications

June 2011
How Will Group Visits for Parkinson’s Disease Fit into the Future of Parkinson’s Disease Care?

May 2011
Why Patients Should be Wary of Chelation Therapy for Parkinson’s Disease

April 2011
Opening the Door to Gene Therapy in Parkinson’s Disease: The Need for Refinement of the Technology and Approach

March 2011
Does it Matter if I Can’t Get Brand Sinemet?

February 2011
Should I get a DaTscan or PET scan to confirm my diagnosis of Parkinson’s disease?

January 2011
A Critical Reappraisal of the Worst Drugs in Parkinson’s Disease

December 2010
Environmental Risks for PD: Manganese, Welding, Mining, and Parkinsonism

November 2010
Calling for the FDA to Revise the Eight Sinemet a Day Rule

October 2010
Dry Cleaning Solvents and Potential Environmental Risks for Developing Parkinson’s Disease

September 2010
Maintaining the Balance: Why Parkinson’s Disease Patients Need to Understand Drug Recalls, Withdrawals, and Safety Alerts

August 2010
Shining a Light on Parkinson’s Disease: Optogenetics Has a Bright Future in Research

July 2010
Poor Medication Management of Parkinson's Disease During Hospital Admissions: Patients and Families Can Improve Their Hospital-Based Management

June 2010
Why Are Patches and Continuous Release Technology a Big Deal to Parkinson's?

May 2010
Is the PD SURG Trial Another Surge Forward for DBS Therapy?

April 2010
Cycling in PD in Those Who Can’t Walk: Is it Possible?

March 2010
New iPS Stem Cells for PD: What Does it Mean?

February 2010
Time for Comprehensive Care Networks for PD

January 2010
Is Parkinson's Disease a Prion Disease?

December 2009
Parkinson's Disease Linked to Gaucher's Disease

November 2009
Brain Cells Keep Time Stamps: Implications for Parkinson's Disease Therapies

October 2009
Is it Safe to Have an MRI with a DBS in Place?

September 2009
Take Care of Your Bones as They Are Affected in Parkinson's Disease (Even in Men)

August 2009
Is it Time to Start Paying Attention to Pain Symptoms in Parkinson's Disease Patients?

July 2009
Glutathione Fails to Demonstrate Significant Improvement in PD Symptoms

June 2009
Keeping an Eye on Trials Important to the Parkinson's Disease Patient

May 2009
Increased Risk of Melanoma in Parkinson's Disease

April 2009
Finally a DBS Expert Consensus Statement Aimed at Their True Customers: The Patients

March 2009
Pesticides and Environmental Exposure in Parkinson's disease: Should We Stay Away From the Stink Truck?

February 2009
Is Exercise Effective Treatment and Protection Against PD?

January 2009
Why are Transplant Trials Struggling to Succeed in the Treatment of PD?

December 2008
Are Monoamine Oxidase Inhibitors Disease Modifying or Neuroprotective in PD?

November 2008
Update on Gene Therapy for Parkinson's Disease

Currently: 5 (1 ratings)

Print

Each month, we will feature a new column by NPF's National Medical Director, Dr. Michael Okun, on the latest developments in Parkinson's disease research. Read the latest "What's Hot in PD?" below.

Subscribe to this blog

RSS